102
Views
14
CrossRef citations to date
0
Altmetric
Review

Chemogenomics approaches to novel target discovery

Pages 411-419 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Lee Harland & Anna Gaulton. (2009) Drug target central. Expert Opinion on Drug Discovery 4:8, pages 857-872.
Read now

Articles from other publishers (13)

Laura Isigkeit & Daniel Merk. (2023) Opportunities and challenges in targeting orphan nuclear receptors. Chemical Communications 59:31, pages 4551-4561.
Crossref
Zhiguo Wang & Baofeng YangZhiguo Wang & Baofeng Yang. 2022. Polypharmacology. Polypharmacology 677 736 .
Joyce Villa Verde Bastos Borba, Arthur Carvalho Silva, Marilia Nunes Nascimento Lima, Sabrina Silva Mendonca, Nicholas Furnham, Fabio Trindade Maranhão Costa & Carolina Horta Andrade. 2021. Protein Kinases in Drug Discovery. Protein Kinases in Drug Discovery 187 223 .
Li Chen, Lynda Stuart, Toshiro K Ohsumi, Shawn Burgess, Gaurav K Varshney, Anahita Dastur, Mark Borowsky, Cyril Benes, Adam Lacy-Hulbert & Emmett V Schmidt. (2013) Transposon activation mutagenesis as a screening tool for identifying resistance to cancer therapeutics. BMC Cancer 13:1.
Crossref
Shayne Cox GadR. Damoiseaux. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia.
Xia Ning & George Karypis. (2011) In silico structure-activity-relationship (SAR) models from machine learning: a review. Drug Development Research 72:2, pages 138-146.
Crossref
Donald J. AbrahamEdgar Jacoby. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery 581 600 .
Anne Kümmel & Christian N. Parker. 2011. Chemoinformatics and Computational Chemical Biology. Chemoinformatics and Computational Chemical Biology 435 457 .
Philip Prathipati, Ngai Ling Ma, Ujjini H. Manjunatha & Andreas Bender. (2009) Fishing the Target of Antitubercular Compounds: In Silico Target Deconvolution Model Development and Validation . Journal of Proteome Research 8:6, pages 2788-2798.
Crossref
Anton A. VolkovNatal’ya S. KruglovaMariya I. MeschaninovaAlya G. VenyaminovaMarina A. ZenkovaValentin V. VlassovElena L. Chernolovskaya. (2009) Selective Protection of Nuclease-Sensitive Sites in siRNA Prolongs Silencing Effect. Oligonucleotides 19:2, pages 191-202.
Crossref
Claude E GagnaW Clark Lambert. (2009) Novel multistranded, alternative, plasmid and helical transitional DNA and RNA microarrays: implications for therapeutics. Pharmacogenomics 10:5, pages 895-914.
Crossref
Riko D. Klootwijk, Paul J. M. Savelkoul, Carla Ciccone, Irini Manoli, Natasha J. Caplen, Donna M. Krasnewich, William A. Gahl & Marjan Huizing. (2008) Allele‐specific silencing of the dominant disease allele in sialuria by RNA interference. The FASEB Journal 22:11, pages 3846-3852.
Crossref
Stephen Gately & Robert West. (2007) Novel therapeutics with enhanced biological activity generated by the strategic introduction of silicon isosteres into known drug scaffolds. Drug Development Research 68:4, pages 156-163.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.